showed a trendP = 0.054
In quartile analysis, compared with the first quartile, the fourth quartile showed a trend toward increased DR risk (OR: 1.60, 95% CI: 0.99–2.59, P = 0.054), with a significant dose-response trend (P for trend = 0.040).
In quartile analysis, compared with the first quartile, the fourth quartile showed a trend toward increased DR risk (OR: 1.60, 95% CI: 0.99–2.59, P = 0.054), with a significant dose-response trend (P for trend = 0.040).
When analyzed by quartiles, compared with Q1, participants in Q3 (OR: 1.44, 95% CI: 1.01–2.06, P = 0.044) and Q4 (OR: 2.27, 95% CI: 1.61–3.22, P < 0.001) showed significantly higher risk of DR in the unadjusted model, with a significant trend across quartiles (P for trend < 0.001).